Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 6, 2026

Stock market today: Dow, S&P 500, Nasdaq sink after jobs report surprise, oil tops $90

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq sink after jobs report surprise, oil tops $90 US stocks tumbled on Friday as the key monthly jobs report surprised to the downside and oil prices surged amid a deepening Middle East conflict, raising inflation worries…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • If February's jobs report came in strong, he would switch to prefer holding rates steady, but given weak reading, he's likely to stick with bias to cut rates

    80% confidence
  • February's job report reflects structural changes in the job market where older Americans are retiring and companies are pausing hiring to see where AI can fill gaps

    80% confidence
  • This jobs report has got my attention. The labor markets may be a little weaker than we have seen so far

    80% confidence
  • Waiting for another 10% drop to Make Tech Value Again

    80% confidence
  • At this point, the Fed is facing two-sided risks

    80% confidence
  • With oil continuing to climb and shipping through Strait still disrupted, fuel prices are likely to keep rising through the weekend

    80% confidence
  • The Middle East conflict could 'bring down the economies of the world' and all Gulf energy exporters would shut down production within days, driving oil to $150 per barrel

    80% confidence
  • The only path to resolution in Iran is 'UNCONDITIONAL SURRENDER'

    80% confidence
  • US will issue waiver allowing India to buy Russian oil stranded at sea

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com